Planning Service is petitioning the FDA to change the designation of St. John’s
Wort from “herbal dietary supplement status” to “behind pharmacy counter
status” (BPCS)—a designation that requires pharmacist consultation. But the
herbal supplement is far safer than any other depression medication, has been
used for many years in Germany and other countries to treat mild depression,
and is as effective as standard antidepressants with fewer side effects.
purchase contingent on a consultation with a pharmacist might dissuade the
consumer from taking St. John’s Wort, and would give a false impression that
SJW is dangerous.
Tell FDA that St.
John’s Wort is a safe, and that the safeguards already built into the system
with the warning on the label are completely adequate. No reclassification to
“behind the counter status” is even remotely warranted.
Please personalize and add your own
comments if you have time!
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP]